• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Laurus Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 45955.0
  • ISIN : INE947Q01028
613.40 -4 (-0.70%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    606.70

  • Today’s High

    626.65

  • Open

    619.90

  • Perv Close

    617.70

  • 52W Low

    385.45

  • 52W High

    646.20

Key Indicators

  • P/E(TTM)

    132.57

  • Mar.Cap (₹Cr.)

    33,077.75

  • Div & Yield %

    0.13

  • Book Value(₹)

    79.18

  • Debt-Equity Ratio

    -0.70

  • AGM Date

    28-Mar-2025

  • EPS

    4.63

  • P/E Ratio

    132.57

Financials Ratios

  • Debt-Equity Ratio

    0.56

  • Mar.Cap (₹Cr.)

    33,077.75

  • RONW (%)

    4.13

  • ROCE (%)

    6.31

Score Board

  • Equity (₹ in Cr.)

    107.85

  • BV (₹)

    79.20

  • Sales( ₹ in Cr.)

    4,812.39

  • NP (in Cr.)

    224.27

  • NP Var(%)

    -71.0

  • Div%

    40.0

  • CPS (₹)

    10.60

  • EPS (₹)

    4.20

  • Traded Value (₹ in Lakhs)

    33,099.32

  • 52 Week High

    646.20

  • 52 Week Low

    385.45

  • Price BSE

    614.0

  • Price NSE

    613.00

  • Market Capital( in Cr.)

    33,099.32

  • P/C Ratio

    58.20

  • P/E Ratio

    147.60

  • Price Vs.BV

    4.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 4,812.39 5,773.45 4,707.04 4,768.72 2,797.34 2,236.15
Excise Duty 4,620.28 5,628.19 4,526.28 4,569.13 2,664.09 2,100.46
Net Sales 4,812.39 5,773.45 4,707.04 4,768.72 2,797.34 2,236.15
Other Income 47.42 15.95 21.55 27.32 5.81 16.13
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 4,859.81 5,789.40 4,728.59 4,796.04 2,803.15 2,252.27
EXPENDITURE :
Raw Materials 4,620.28 5,628.19 4,526.28 4,569.13 2,664.09 2,100.46
Power & Fuel Cost 4,620.28 5,628.19 4,526.28 4,569.13 2,664.09 2,100.46
Employee Cost 552.21 496.57 445.14 401.88 324.00 269.72
Other Manufacturing Expenses 29.62 44.30 15.33 10.48 10.62 16.92
Selling & Administrative Expenses 278.23 308.55 240.91 226.03 168.05 134.63
Miscellaneous Expenses 29.62 44.30 15.33 10.48 10.62 16.92
Less : Pre-operative Expenses Capitalised :
Total Expenditure 4,558.34 4,737.97 3,753.18 3,521.41 2,498.67 2,131.05
Operating Profit 797.06 729.80 511.90 445.33 321.89 254.49
Interest 150.82 145.70 95.86 65.92 87.71 85.83
Gross Profit 301.47 1,051.43 975.41 1,274.63 304.48 121.22
Depreciation 345.01 300.58 235.48 196.64 183.85 160.53
Profit Before Tax 301.47 1,051.43 975.41 1,274.63 304.48 121.22
Tax 87.94 270.78 231.42 334.98 53.00 24.83
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.17 20.27 -6.10 -16.46 -15.57 1.39
Reported Net Profit 223.70 760.38 750.09 956.11 267.05 94.99
Extraordinary Items 301.47 1,051.43 975.41 1,274.63 304.48 121.22
Adjusted Net Profit 223.70 760.38 750.09 956.11 267.05 94.99
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 43.10 107.41 107.41 107.28 26.66 15.97
P & L Balance carried down 223.70 760.38 750.09 956.11 267.05 94.99
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 40.00 100.00 100.00 100.00 25.00 15.00
Dividend Per Share(Rs) 0.80 2.00 2.00 2.00 2.50 1.50
Earnings Per Share-Unit Curr 4.15 14.14 13.97 17.85 5.01 8.94
Book Value 43.10 107.41 107.41 107.28 26.66 15.97
Book Value(Adj)-Unit Curr 43.10 107.41 107.41 107.28 26.66 15.97

Shareholding Pattern

  • Promoter Group

    27.62%

  • Public Share Holding

    72.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,122,476 3.36 18,122,476 14
Partnership Firms-Indian (Promoter & Group) 130,831,740 24.26 130,831,740 2
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 148,954,216 27.62 148,954,216 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 11 0.00 11 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 137,811,306 25.56 137,811,306 184
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 22,004,717 4.08 22,004,717 10
Mutual Funds / UTI 41,085,538 7.62 41,085,538 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,613,047 1.04 5,613,047 17
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 206,514,619 38.30 206,514,619 237
2] Non Institution
Bodies Corporate 43,976,735 8.16 43,976,735 1,321
Clearing Members 26,832 0.01 26,832 11
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 11,197,991 2.08 11,197,991 5,764
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,221,240 0.41 2,221,240 3,748
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 47,578,174 8.82 47,562,674 92
Individuals holding nominal share capital up to Rs. 1 lakh 74,950,351 13.90 74,872,674 281,014
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 3,830,408 0.71 3,830,408 10
Others 1,925 0.00 1,925 1
Sub Total 183,783,656 34.08 183,690,479 291,961
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 539,252,491 100.00 539,159,314 292,214

Company Background

Laurus Labs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Laurus Labs Ltd
  • BSE Code : 45955.0
  • ISIN : INE947Q01028

  • Incorporation Year

    2005

  • Registered Office

    Plot No 21 Jawaharlal Nehru
    Pharma City Parawada, Visakhapatnam,
    Andhra Pradesh-531021

  • Telephone

    91-891-3061222

  • FAX

    91-891-3061270

  • Chairman

    Ravindranath Kancherla

  • Managing Director

  • Company Secretary

    G Venkateswar Reddy

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Laurus Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Laurus Labs 613.80 4,859.81 4,812.39 132.57 7.34
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92